ClinicalTrials.gg
Enrolling by invitationNCT07477899COREUpdated Mar 23, 2026

Growing Up in Multifactorial Risk Conditions

An interventional study of Home visiting programme in Adverse Childhood Experiences, Developmental Risk and Psychomotor Development Disorders, sponsored by IRCCS Eugenio Medea. Enrolling by invitation at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jun 2024, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
352
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 35 studies in Neurodevelopmental Disorders with a site in Italy — 18 open to participants now, 24 under way, 6 of them phase 3. Neurodevelopmental Disorders · Italy.

Planned enrollment
2nd of 25
352 · median 80
Started
2024
with 9 others
No phase
18 of 35
9 open now
Primary completion
2027-09
later than 18 of 23 live
Registered
32nd of 35
by date
Lead sponsor
7 of 35
IRCCS Eugenio Medea

Among the 35 studies in Neurodevelopmental Disorders with a site in Italy, this one is the 2nd largest by planned enrollment of the 25 interventional ones, is one of 10 that started in 2024, is one of 18 with no phase, reaches primary completion later than 18 of the 23 other live ones, and was the 32nd registered.

By phase

35 studies; the count open now beside each. This study's row is marked.

No phasethis study18 · 9 open
Observational10 · 6 open
Phase 36 · 3 open
Phase 11 · 0 open

By the year they started

First in 2016; this study’s year is marked. 10 started in 2024.

Size and results

Median enrollment 80 across the 25 interventional studies, 139 across the 10 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 35 studies in Neurodevelopmental Disorders with a site in Italy, or all of them as a file.
02

Study summary

The perinatal period brings significant physiological and emotional changes in mothers, linked to pregnancy, childbirth, and caring for a newborn. While pregnancy is often experienced positively, various stressors can impact maternal well-being and child health. Maternal stress can lead to vascular issues (e.g., hypertension, preeclampsia) or mental health concerns like depression and anxiety. Recent studies show depressive symptoms occur in 41.45% of women in the first trimester, with clinical depression in 9.85%. Postpartum depression has an estimated incidence of 10-20%, with strong continuity from prenatal depression. Stressors, including adverse childhood experiences (ACEs) and maternal psychological issues, often lead to emotional dysregulation. This, through intergenerational transmission, can impact a child's emotional regulation into adolescence.

Intergenerational transmission involves both biological mechanisms (endocrine, neurophysiological, epigenetic) and social mechanisms (parenting style, early relationship quality). Sensitive, reciprocal adult-child interactions are essential for socio-emotional and cognitive development, and a child's emotional regulation abilities predict later emotional-behavioral issues.

Understanding perinatal risk predictors is key to developing programs that reduce such risks. For example, factors like ACEs, unfavorable conditions, complications during pregnancy, and neurodevelopmental challenges in children can negatively affect the child's cognitive, emotional, and behavioral functioning, maternal well-being, epigenetic changes, and dyadic synchrony. Yet, risk factors do not prevent adaptation and may coexist with protective factors that support maternal well-being and child development.

Early parenting support is thus essential, particularly in cases with multiple risks. Research indicates that challenges in implementing support programs often arise from insufficient identification of women at risk of psychological distress during pregnancy and postpartum. In many cases, these issues go unrecognized and untreated, or intervention happens late. It is crucial that prenatal screenings assess potential risk factors to identify women who could benefit from psychological and parenting support starting early in pregnancy. Such multidisciplinary interventions aim to limit intergenerational transmission of mental health issues, reducing impact on a child's emotional, behavioral, and cognitive development. Evidence increasingly supports that Home Visiting (HV) programs benefit both maternal mental health and child development. These programs help mothers manage psychopathological risks and parenting stress while fostering strong attachment and interactions that promote the child's emotional-behavioral development.

Primary Objectives

To investigate, at 18 months of child age (adjusted for prematurity), whether for mothers with perinatal risk, an HV-based parenting support intervention affects:

1.1. The child's emotional-behavioral profile, using the Child Behavioral Checklist 1.5/5 (CBCL);

1.2. Maternal mental well-being, using the Mental Health Continuum-Short Form (MHC-SF).

Secondary Objectives

Considering cumulative perinatal risk factors, examine if the HV program:

2.1. Increases maternal well-being for the ACE+ group from T0 (pre-intervention, first trimester) to T8 (post-intervention, child at 18 months);

2.2. Promotes mother-child synchrony at 3 months, in relational functioning (mother-child behavior) and cardio-respiratory activity (HRV and RSA);

2.3. Enhances child developmental competencies at 3 and 18 months (domains: (1) motor, (2) adaptive behaviors, (3) socio-emotional, (4) cognitive, (5) communication).

Exploratory Objectives

Examine if the HV program influences the epigenetic status of mothers (pre- and postnatal) and children (at 3 months). DNA methylation variations will be assessed in mothers and children in the HV program group versus controls, focusing on target genes related to stress regulation (SLC6A4, NR3C1, BDNF), neural plasticity (BDNF), social interaction (DRD4, OXTR), and tactile stimulation perception (Piezo1, Piezo2, TRPV1, TRPM8, MRGPRB4). Additional candidate genes will be identified through computational research.

Read the detailed description

The perinatal period-defined as the span from conception to the first two years of life-is marked by significant physiological and emotional changes in the mother, associated with pregnancy, childbirth, and neonatal care. Although pregnancy is often experienced positively by most parents, various stressors can considerably impact maternal well-being (and that of the couple), as well as fetal and child health. Maternal stress can induce physiological effects, such as vascular disorders (e.g., hypertension and preeclampsia), or affect mental health, leading to conditions like depression and anxiety. A recent study reports a 41.45% prevalence of depressive symptoms and a 9.85% prevalence of depression during the first trimester. Postpartum depression is estimated to occur in 10-20% of cases, with significant continuity from prenatal to postnatal depression. Numerous stressors, including a prior history of adverse experiences and/or trauma (i.e., Adverse Childhood Experiences, ACEs), and the occurrence of maternal psychological disorders during the perinatal period often co-occur with emotional dysregulation. Through intergenerational transmission mechanisms, this may impair a child's ability to regulate emotions, with effects extending into adolescence.

Intergenerational transmission involves both biological mechanisms (e.g., endocrine, neurophysiological, epigenetic processes) and socio-relational mechanisms (e.g., parenting style and early relationship quality). For instance, a sensitive, reciprocal adult-child interaction is essential for fostering the child's socio-emotional and cognitive development. The child's ability to regulate emotions serves as an important predictor of later dysfunctional behaviors and emotional or behavioral problems in early childhood.

Understanding predictors of perinatal psychological challenges is crucial for implementing risk reduction programs. Risk factors such as adverse personal history (ACE), unfavorable conditions, pre-, peri-, and post-natal complications, and the child's neurodevelopmental challenges may negatively impact the child's cognitive and emotional-behavioral functioning, maternal well-being, epigenetic modifications in both mother and child, and dyadic synchrony. Conversely, risk factors do not preclude positive adaptation and can coexist with protective factors that enhance maternal well-being and child development.

Thus, early parental support interventions are fundamental as protective factors, especially in contexts where multiple risk factors coexist . Evidence suggests that barriers to implementing support interventions often stem from insufficient early identification of women at risk for psychological distress during pregnancy and postpartum. Frequently, these conditions are undetected and untreated, or support begins only when the woman's distress has significantly progressed. Consequently, prenatal screenings should assess potential risk factors to identify women who may benefit from psychological and parenting support interventions starting in the early months of pregnancy. Such multidisciplinary interventions aim to mitigate or halt the intergenerational transmission of mental health issues, thus reducing the impact on the child's emotional, behavioral, and cognitive development.

Objectives

Primary Objective: To investigate, at 18 months of child age (adjusted for prematurity), whether a home-visiting (HV) parental support program for women at perinatal risk impacts:

Objective 1.1: the child's emotional-behavioral profile, assessed with the Child Behavioral Check-List 1.5/5 (CBCL); Objective 1.2: maternal mental well-being, assessed using the Mental Health Continuum-Short Form (MHC-SF).

Secondary Objective: Assessing the cumulative impact of perinatal risk factors, determine if the HV program facilitates:

Objective 2.1: an improvement in maternal mental well-being in the ACE+ group from T0 (pre-intervention assessment: first trimester) to T8 (post-intervention assessment: 18 months postpartum); Objective 2.2: mother-child synchrony at 3 months postpartum concerning relational functioning (maternal and child behavior) and cardio-respiratory activity (heart rate variability, HRV; respiratory sinus arrhythmia, RSA); Objective 2.3: development of child competencies across key domains (motor, adaptive behaviors, socio-emotional, cognitive, and communication skills) at 3 and 18 months.

Study Design The study employs a multicenter, interventional, prospective design with longitudinal data collection, implemented within an ASST Brianza Service aimed at identifying "at-risk" pregnant women based on ACE questionnaire scores (Adverse Childhood Experiences; Felitti, 2013). The service, titled "WECAREGENERATION-1000days" (Resolution.0000808.21-09-2023), includes home visits conducted by trained professionals (midwives), where psychosocial intervention is delivered from early pregnancy through the child's first 18 months.

Intervention: Home Visiting and Psychosocial Support Program The Lombardy Region identified HV as an effective strategy for promoting maternal and neonatal physical and mental health, using the "Positive Thinking" guide, developed by the World Health Organization (WHO, 2015), for managing perinatal depression and providing structured psychosocial support. The program includes an introductory session and five modules covering the perinatal and postpartum periods. Each module is adapted to the child's developmental stage and maternal needs, emphasizing maternal well-being, mother-child relationship, and relationships with significant others.

Recruitment Recruitment will take place in ASST Brianza's maternal health centers. During the first obstetric booking, eligible pregnant women will be informed about the study, and consent will be obtained. Women with an ACE score ≥3 who agree to participate will form the clinical ACE+ group. A control ACE- group will be selected from non-risk pregnant women (ACE \< 3), with assessments added to standard care to measure study outcomes.

Study Phases The longitudinal study includes baseline (T0 = first trimester) and endpoint (T8 = 18 months postpartum) assessments, with six intermediate follow-ups.

F1: Baseline T0-Mental health (MHC-SF) and sociodemographic questionnaires. F3: T2, third trimester-Maternal epigenetic status from saliva samples; emotional status assessed with DASS-21.

F4: T3, postnatal-Biomedical risk profile assessment for neonate. F5-F7: Follow-up (3, 6-12, and 18 months)-Epigenetic sampling, developmental profile evaluation, and video assessment of mother-child interaction.

Adherence to Procedures

The procedures outlined in the study protocol (e.g., video recording of mother-infant interactions) are utilized in the pediatric field. Additionally, the Principal Investigator (PI) possesses extensive experience with the methodologies employed and applied in various studies conducted at the 0-3 Center of the IRCCS "Eugenio Medea," involving mothers and infants aged between 0 and 18 months, the results of which have been the subject of several scientific publications. Therefore, based on the PI's prior experience, no significant difficulties regarding adherence to the intervention by the parents participating in this study are anticipated. Moreover, certain characteristics of the study may promote adherence among mothers, specifically:

The procedures outlined in the protocol (e.g., questionnaire completion) related to the intervention will be integrated into the routine practices of the regional health service, eliminating the need for additional visits.

Following the initial obstetric booking (T0), mothers will receive home visits, a practice that, by minimizing the need to travel to outpatient services, is likely to facilitate greater adherence to the study.

The video recording of mother-infant interaction at three months of age (T4) will take place at the 0-3 Center, necessitating travel for the mother (and her infant) from home to the IRCCS Medea. Considering the geographic area of interest of ASST-Brianza and the location of the IRCCS Medea, it is estimated that the maximum distance a participating mother may need to travel will not exceed 25 kilometers. The commitment required for the video recording is approximately 30 minutes, accounting for the welcome phase, infant adaptation, and the time needed to put on the sensor-equipped shirts. To promote adherence, mothers are encouraged to be accompanied by a relative.

Typically, mothers welcome participation in video-recorded interactions. In this context, mothers are highly motivated to engage, particularly because they receive feedback on their child's development and interaction patterns. If requested, they are provided with a copy of the video.

Mothers will benefit from both obstetric and psychosocial support from qualified and trained personnel, which generally serves as a motivating factor for women during the transition to parenthood.

Mothers may also be motivated by the opportunity to gain insights into their child's emotional-behavioral functioning up to 18 months of age, which can serve as an incentive for participation and completion of all study phases.

All these procedures are conducive to promoting adherence among study participants. It is essential that mothers (and fathers) understand all requests made of them and have the opportunity to ask any questions they may have.

Assessment of the Benefit/Risk Ratio for the Population

The project presents an optimal balance between risks and benefits.

Potential Risk Factors:

Novelty: The project is characterized as innovative; however, existing literature, the experience of the researchers involved, and the preliminary evaluation of more innovative procedures (e.g., the use of sensor-equipped shirts for bio-signal acquisition, which, combined with behavioral analyses, may serve as proxies for assessing the quality of early mother-infant interactions) suggest that participation in the study poses no undesirable effects or risks to participants (children, women).

Tolerance to Experimental Procedures: The study involves procedures that have already been utilized in pediatrics, many of which have been employed in previous studies conducted at the 0-3 Center. Moreover, all procedures (i.e., saliva collection, video recording of mother-infant interaction) will be promptly halted if the infant shows signs of irritation, crying, or discomfort, or if the parent expresses an unwillingness to continue, regardless of the reasons provided.

Potential Benefits:

The possibility of monitoring/supporting the mental health status of women during the transition to parenthood and the psychosocial development of the child.

Acquisition of evidence regarding the bio-behavioral mechanisms underlying the potential protective effect that an early parenting support program could have on primary and secondary outcomes.

The multifactorial approach adopted (considering adverse experiences in the mother's history, unfavorable psychosocial conditions, pre-, peri-, and postnatal complications, and neurodevelopmental difficulties in the child) will enhance understanding of the biological and behavioral processes involved in intergenerational transmission and associated with reduced emotional regulation capacity in children.

The study will facilitate synergy between a research center (IRCCS) and the territorial services provided by the regional health service (ASST Brianza), with the potential to develop best practices for screening, assessment, and early intervention in families deemed at risk.

03

Conditions studied

  • Adverse Childhood Experiences
  • Developmental Risk
  • Psychomotor Development Disorders
  • Neurodevelopmental Disorders
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Good understanding of the Italian language
  • No cognitive impairments and/or diagnosed psychiatric disorders
  • No use of psychotropic medications
  • Participation in the parental support program (only for the ACEs+ group)

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
352 participants (estimated)

Study arms

  • Experimental
    ACE +

    Pregnant women who have scored ≥ 3 on the Adverse Childhood Experiences (ACE) questionnaire.

    Behavioral: Home visiting programme

  • No intervention
    ACE -

    Pregnant women who have scored \< 3 on the Adverse Childhood Experiences (ACE) questionnaire.

Interventions

  • BehavioralHome visiting programme

    This intervention aims to help women identify their resources and abilities, as well as to support them in choosing strategies that are most effective for maintaining individual and family balance. Additionally, by strengthening maternal mental health, the intervention is designed to enhance parental competencies, contributing to the establishment of a positive foundation for the development of their children.

06

What researchers measure

Primary outcomes

  1. Child emotional-behavioral profile

    Child emotional and behavioral functioning assessed using the Child Behavior Checklist for ages 1.5-5 years (CBCL/1.5-5)

    Time frame: At 18 months of child age (corrected age for prematurity)

  2. Maternal mental well-being

    Maternal mental well-being assessed using the Mental Health Continuum-Short Form (MHC-SF)

    Time frame: At 18 months postpartum

Secondary outcomes

  1. Change in maternal mental well-being

    Maternal mental well-being assessed using the Mental Health Continuum-Short Form (MHC-SF), comparing scores from the first trimester of pregnancy to 18 months of child age

    Time frame: Once during the first trimester of pregnancy and once at 18 months postpartum

  2. Mother-infant synchrony

    Mother-infant synchrony assessed through observational measures of relational functioning and cardiorespiratory activity (HRV and RSA)

    Time frame: At 3 months of child age

  3. Child development

    Child development including communication, gross motor, fine motor, problem solving, and personal-social skills assessed using the Developmental Profile 4 (DP4)

    Time frame: At 3 months and 18 months of child age

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Sep 2027, 39 months after the start.

Of 142 non-industry interventional studies with no phase under Neurodevelopmental Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 52. This study's planned 39 months is above that.

Counting every sponsor, half of 148 studies reached it within 30 months; a quarter within 15 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2026
First posted
Mar 17, 2026
StartActual
Jun 26, 2024
Primary completionEst.
Sep 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07477899
Collaborators
Azienda Socio Sanitaria della Brianza
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Jun 26, 2024
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion